DiogenX
Latest round
- Series A
Last raised
- May 2023
Total raised
- $35M
Investors
- 6
About DiogenX
Founded in 2020 and headquartered in Marseille, France, DiogenX specializes in biologics aimed at treating Type 1 Diabetes. The company is co-founded by Benjamin Charles and Patrick Collombat.DiogenX specializes in developing innovative biologics aimed at treating Type 1 Diabetes (T1D) through the regeneration of insulin-producing pancreatic beta cells. The company's lead program, DGX-01, utilizes a proprietary approach to modulate the Wnt/ß-catenin signaling pathway, aiming to restore pancreatic function and provide a disease-modifying therapy for T1D patients.DiogenX's revenue model is based on partnerships and collaborations with major pharmaceutical companies and research institutions in the biopharma sector. The company aims to expand its market presence, particularly targeting regions with significant T1D prevalence. Plans for future product launches include advancing DGX-01 through clinical trials, although specific release dates have not been disclosed.
Who invested in DiogenX
6 investors across 2 rounds
See all investors in DiogenX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DiogenX
Who invested in DiogenX?
DiogenX has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DiogenX raised?
DiogenX has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did DiogenX last raise money?
DiogenX's most recent round on record is a Series A, in May 2023.
What does DiogenX do?
Founded in 2020 and headquartered in Marseille, France, DiogenX specializes in biologics aimed at treating Type 1 Diabetes.
Where is DiogenX headquartered?
DiogenX is headquartered in Marseille, France.
Which VCs invest in companies like DiogenX?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at DiogenX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like DiogenX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.